BackgroundCheck.run
Search For

Zhong L Zhang, 57Concord, MA

Known as:
Zhang Zhong
Related to:
Bok H Chang 51 Xulei Wang 54

Zhong Zhang Phones & Addresses

Concord, MA   

32 Pokonoket Ave, Sudbury, MA 01776    978-4407671   

23 Church St, Waltham, MA 02452    781-7880115   

180 Main St, Bridgewater, MA 02324   

137 Worthen Rd, Lexington, MA 02421    781-5386279   

Schenectady, NY   

North Chelmsford, MA   

New Bedford, MA   

Amherst, MA   

Work

Position: Professional/Technical

Education

Degree: Associate degree or higher
Get Report
Control this profile

Mentions for Zhong L Zhang

Career records & work history

Lawyers & Attorneys

Zhong Zhang Photo 1

Zhong Zhang - Lawyer

Office:
Zhang & Associates, LLC
Specialties:
General Practice, Immigration
ISLN:
913832415
Admitted:
1997
University:
Fudan University, M.A., 1977
Law School:
University of Maine, School of Law, J.D., 1996

Medicine Doctors

Zhong Zhang Photo 2

Zhong John Zhang

Specialties:
Pathology
Anatomic Pathology & Clinical Pathology
Hematology
Clinical Pathology/Laboratory Medicine
Hematology
Pediatric Otolaryngology
Education:
Nanjing University Medical College (1986)

Zhong Zhang resumes & CV records

Resumes

Zhong Zhang Photo 37

Product Development Engineer

Work:

Product Development Engineer
Zhong Zhang Photo 38

Senior Reservoir Engineer

Industry:
Oil & Energy
Work:
Shell China Exploration and Production Company Limited
Senior Reservoir Engineer
Zhong Zhang Photo 39

Chief Executive Officer Of Combimed Inc

Location:
Sudbury, MA
Industry:
Medical Devices
Work:

Chief Executive Officer of Combimed Inc Transform Pharmaceuticals 2000 - 2008
Scientist Johnson & Johnson 2000 - 2008
Scientist
Zhong Zhang Photo 40

Zhong Zhang

Zhong Zhang Photo 41

Computational Biologist At Broad Institute

Location:
Greater Boston Area
Industry:
Research
Zhong Zhang Photo 42

Zhong Zhang

Location:
United States

Publications & IP owners

Us Patents

Proteins Within The Type E Botulinum Neurotoxin Complex

US Patent:
6699966, Mar 2, 2004
Filed:
Apr 10, 2000
Appl. No.:
09/546136
Inventors:
Bal Ram Singh - Dartmouth MA
Zhong Zhang - New Bedford MA
Assignee:
University of Massachusetts - Boston MA
International Classification:
C07K 1400
US Classification:
530350, 530300, 514 2, 514 12, 424 941
Abstract:
The invention features a polypeptide complex synthesized by bacteria of the genus Clostridia that contains the serotype E botulinum neurotoxin and five neurotoxin associated polypeptides having molecular weights of about 118, 80, 65, 40, and 18 kDa, respectively. The complex is useful in the treatment of diseases or conditions that are caused by excessive release of acetylcholine from presynaptic nerve terminals.

Proteins Within The Type E Botulinum Neurotoxin Complex

US Patent:
7431935, Oct 7, 2008
Filed:
Jan 27, 2004
Appl. No.:
10/766283
Inventors:
Bal Ram Singh - Dartmouth MA, US
Zhong Zhang - New Bedford MA, US
Assignee:
University of Massachusetts - Boston MA
International Classification:
C07K 14/00
A61K 38/00
A61K 38/43
US Classification:
4242391, 4242361, 424 91, 514 2, 514 12, 530350, 4352527
Abstract:
The invention features a polypeptide complex synthesized by bacteria of the genus that contains the serotype E neurotoxin and five neurotoxin associated polypeptides having molecular weights of about 118, 80, 65, 40, and 18 kDa. respectively. The complex is useful in the treatment of diseases or conditions that are caused by excessive release of acetylcholine from presynaptic nerve terminals.

Aqueous Pharmaceutical Compositions Of 2,6-Diisopropylphenol (Propofol) And Their Uses

US Patent:
7550155, Jun 23, 2009
Filed:
Jan 28, 2004
Appl. No.:
10/766631
Inventors:
Zhong Zhang - Sudbury MA, US
Orn Almarsson - Shrewsbury MA, US
Hongming Chen - Acton MA, US
Assignee:
Transform Pharmaceuticals Inc. - Lexington MA
International Classification:
A61K 9/14
US Classification:
424486
Abstract:
The present invention provides aqueous pharmaceutical compositions containing a lipophilic therapeutic agent. In particular, the invention provides aqueous pharmaceutical compositions containing the compound 2,6-diisopropylphenol (propofol). Preferred compositions of the invention contain propofol in the presence of at least one block copolymer (for example, P188 or another poloxamer) and a polyethylene glycol (PEG). Compositions of the invention are preferably sterile or are readily sterilized (e. g. , by autoclaving) and are suitable for parenteral administration to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions and for extended periods of time.

Aqueous 2,6-Diisopropylphenol Pharmaceutical Compositions

US Patent:
7915317, Mar 29, 2011
Filed:
Jul 29, 2003
Appl. No.:
10/629308
Inventors:
Zhong Zhang - Sudbury MA, US
Orn Almarsson - Shrewsbury MA, US
Hongming Chen - Acton MA, US
Assignee:
Transform Pharmaceuticals, Inc. - Lexington MA
International Classification:
A61K 31/05
A61K 31/14
US Classification:
514731, 514643
Abstract:
The present invention relates to aqueous pharmaceutical compositions comprising 2,6-diisopropylphenol (propofol). A composition of the present invention can comprise propofol and two or more excipients as an aqueous mixture. The propofol containing compositions are preferably sterile and are parenterally administered to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions.

Proteins Within The Type E Botulinum Neurotoxin Complex

US Patent:
7981432, Jul 19, 2011
Filed:
Oct 7, 2008
Appl. No.:
12/247124
Inventors:
Bal Ram Singh - Dartmouth MA, US
Zhong Zhang - New Bedford MA, US
Assignee:
University of Massachusetts - Shrewsbury MA
International Classification:
C07K 14/00
A61K 38/00
A61K 38/43
US Classification:
4242391, 4242361, 424 91, 512 2, 512 12, 530350
Abstract:
The invention features a polypeptide complex synthesized by bacteria of the genus that contains the serotype E botulinum neurotoxin and five neurotoxin associated polypeptides having molecular weights of about 118, 80, 65, 40, and 18 kDa, respectively. The complex is useful in the treatment of diseases or conditions that are caused by excessive release of acetylcholine from presynaptic nerve terminals.

Aqueous Pharmaceutical Compositions Of 2,6-Diisopropylphenol (Propofol) And Their Uses

US Patent:
8133918, Mar 13, 2012
Filed:
Dec 12, 2008
Appl. No.:
12/333887
Inventors:
Zhong Zhang - Sudbury MA, US
Orn Almarsson - Shrewsbury MA, US
Hongming Chen - Acton MA, US
Assignee:
Janssen Biotech, Inc. - Horsham PA
International Classification:
A61K 31/05
A61K 31/14
US Classification:
514731, 514643
Abstract:
The present invention provides aqueous pharmaceutical compositions containing a lipophilic therapeutic agent. In particular, the invention provides aqueous pharmaceutical compositions containing the compound 2,6-diisopropylphenol (propofol). Preferred compositions of the invention contain propofol in the presence of at least one block copolymer (for example, P188 or another poloxamer) and a polyethylene glycol (PEG). Compositions of the invention are preferably sterile or are readily sterilized (e. g. , by autoclaving) and are suitable for parenteral administration to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions and for extended periods of time.

Oral Pharmaceuticals Formulation Comprising Paclitaxel, Derivatives And Methods Of Administration Thereof

US Patent:
2004009, May 13, 2004
Filed:
Feb 5, 2003
Appl. No.:
10/344018
Inventors:
Hongming Chen - Acton MA, US
Zhong Zhang - Sudbury MA, US
International Classification:
A61K038/00
US Classification:
514/002000
Abstract:
The invention concerns excipients or combinations thereof suitable for preparing an oral formulation containing a pharmaceutical agent. More particularly, the invention is directed to stable, efficacious and bioavailable oral pharmaceutical formulations comprising paclitaxel, derivatives of paclitaxel and pharmaceutically acceptable salts thereof. The formulations of the invention increase bioavailability of paclitaxel when dissolved in the gastrointestinal system. The formulations of the invention are useful for administering paclitaxel, its derivatives, or pharmaceutically acceptable salts of such derivatives to patients in need thereof. The formulations of the invention are particularly suitable for oral administration to mammals including humans.

Aqueous 2,6-Diisopropylphenol Pharmaceutical Compositions

US Patent:
2004022, Nov 4, 2004
Filed:
Oct 2, 2003
Appl. No.:
10/677747
Inventors:
Zhong Zhang - Sudbury MA, US
Orn Almarsson - Shrewsbury MA, US
Hongming Chen - Acton MA, US
Burgess Paul - Lexington MA, US
Assignee:
TransForm Pharmaceuticals, Inc. - Lexington MA
International Classification:
A61K031/05
US Classification:
514/731000
Abstract:
The present invention relates to aqueous pharmaceutical compositions comprising 2,6-diisopropylphenol (propofol). A composition of the present invention can comprise propofol and two or more excipients as an aqueous mixture. The propofol containing compositions are preferably sterile and are parenterally administered to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions.

Isbn (Books And Publications)

Polymer Composites: From Nano To Macro-Scale

Author:
Zhong Zhang
ISBN #:
0387241760

Treatise On Febrile Diseases Caused By Cold With 500 Cases

Author:
Zhong Jing Zhang
ISBN #:
0835113981

Public records

Vehicle Records

Zhong Zhang

Address:
32 Pokonoket Ave, Sudbury, MA 01776
Phone:
978-4407671
VIN:
WBAVC73537KP36813
Make:
BMW
Model:
3 SERIES
Year:
2007

Possible Relatives

David Zhang  Dawei Zhang  Dazhi Zhang  De K Zhang  Da Q Zhang  Dachuan Zhang  Daijun Zhang  Zhong Li  Zhong Lin  Zhong Liu 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.